Mapping Genome-wide DNA Damage in Leukemias

News   Jun 19, 2017 | Original story from Children's Hospital of Philadelphia

 
Mapping Genome-wide DNA Damage in Leukemias

A small, hypolobated megakaryocyte in a bone marrow aspirate, typical of chronic myelogenous leukemia. Credit: Difu Wu

 
 
 

RELATED ARTICLES

IDEX Health & Science Announces Acquisition of New Microfluidics Company

News

IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

READ MORE

Agent Reverses Resistance to Targeted Drug in Some Leukemias

News

After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.

READ MORE

Blueprints for Anti-cancer Drugs Identified in Bacterial Genomes

News

Scientists have now brought the family of LNM molecules even closer to clinical testing by “mining” the information stored in bacteria genomes. Their research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE